During this webinar, members of the STS Task Force on Robotic Cardiac Surgery will describe surgical techniques and strategies for the management of complex robotic mitral valve disease, including mitral annular calcification (MAC), systolic anterior motion (SAM), and bileaflet Barlow’s disease. Attendees will leave with a clearer framework for approaching these challenging pathologies and for expanding the range of mitral cases they can confidently treat with a robotic platform.
Gain comprehensive insight about the multidisciplinary team’s role in guiding patients with resectable gastroesophageal junction cancer through the full course of care, including surgery, neoadjuvant, and adjuvant treatment. Faculty will discuss how to establish clear patient expectations, review recent trial data and surgical outcomes (including perspectives on overall survival results from CheckMate 577 and Matterhorn), and operating after neoadjuvant immunotherapy and targeted therapies through evidence-based best practices.
A diverse panel of surgeons from Latin America and the United States will explore three different techniques of minimally invasive thymectomy, highlighting technical pearls and challenges.
Presented in Spanish (and some Portuguese) with English subtitles
Moderators
Francina Bolaños Morales, MD Instituto Nacional de Enfermedades Respiratorias Mexico City, Mexico
A world-class, international event that will explore the latest developments and best practices in coronary artery disease, congenital heart disease, thoracic aortic disease, atrial fibrillation, and the surgical management of heart failure
Join the next installment of the STS/SCA webinar series, Across the Drapes: Intraoperative Disasters and Crises in Cardiac Surgery. Surgery and anesthesiology leaders will discuss strategies to improve collaborative intraoperative management. This second webinar in the series will focus on pulmonary artery catheter (PAC) rupture, cardiac arrest during induction, and TAVR rupture.
A collaborative series presented by the Society of Thoracic Surgeons and the Society of Cardiovascular Anesthesiologists
The premier annual event in cardiothoracic surgery, unveiling never-before-seen science, techniques, and technology, and creating a forum to build lasting connections with colleagues.
Best Practices for Cardiothoracic Surgery is a two-day virtual event that provides coders, surgeons, and billing professionals with the latest updates to CPT and physician coding and reimbursement, which affect cardiothoracic surgical practices.
The management of stage IIIA non-small cell lung cancer (NSCLC) is evolving in the era of immune checkpoint inhibitor therapy. In the past, there has been a great deal of controversy regarding the optimal management of patients with N2 nodal metastasis at the time of diagnosis of NSCLC. There are some new questions to address when considering the results of the Checkmate 816 and the NADIM II clinical trials which demonstrated improved disease-free survival and overall survival with neoadjuvant combined chemotherapy and Nivolumab.
Recent approvals by the U.S. Food and Drug Administration (FDA) have made available two new technologies for treating aortic disease. The GORE® TAG® Thoracic Branch Endoprosthesis (TBE) is single-branch aortic stent graft that provides an off-the-shelf solution for patients that need zone II aortic coverage and obviates the need for prior left subclavian revascularization. The Thoraflex Hybrid Frozen Elephant Trunk (FET) device is a pre-mated surgical graft and an aortic stent graft to facilitate single-stage treatment of arch and proximal descending aortic pathologies.
Last year, the lung transplant community was excited by reports from Toronto General Hospital of successful lung transplants with seemingly improved perioperative outcomes compared to standard of care ice storage, after donor lungs were stored for up to 16 hours at 10 degrees Celsius. While a clinical trial is ongoing, preclinical evidence suggests that organ storage may be successfully extended to more than a day, with intermittent normothermic ex-vivo lung perfusion (EVLP) utilization. Is it time to consider lung transplantation as a semi-elective procedure?
